SBT-0704: A Covid-19 Therapeutic Drug Candidate
Seeking partnerships of a pharmaceutical company to advance clinical testing, or Sale of an antiviral drug for COVID-19: the company is currently developing potential antiviral compounds for the primary drug candidate, SBT-0704. The drug is designed both for prophylactic and antiviral use and is intended to be administered via a single-use inhaler. SBT-0704 brings the power to fight COVID directly to the us...